Bernard Tawfik MD, is Assistant Professor in Department of Internal Medicine, Division of Hematology Oncology and a board certified, practicing medical oncologist at the University of New Mexico Cancer Comprehensive Center (UNM CCC). His clinical interest lies in the treatment of solid tumors with a focus on breast cancer and neuroendocrine tumors. His research has focused on the cancer care delivery, quality improvement and health disparities research.  He is actively involved in the conduct of clinical trials, is involved in the Breast Cancer Working Group Protocol Development Committee at UNM CCC, and sits on the Data Safety Monitoring Committee for the UNM CCC. He has cultivated collaboration with UNM Behavioral Measurement and Population Sciences and the New Mexico Department of Health.  These collaborations have resulted in an investigator initiated clinical protocol evaluating the use of Patient Reported Outcomes (PRO) to assess patient, staff and provider views and patient understanding of adjuvant endocrine therapy. He has further collaborations and publications regarding oral oncolytic adherence, safety and education, effective delivery of Survivorship Care Plans, effectiveness of tumor marker surveillance in early stage breast cancer, improving germline genetic testing rates in pancreatic cancer and, decreasing chemotherapy infusion wait times. He has made significant outreach to the community with several invitations to local and regional conferences educating local providers, cancer survivors and the general population.  He serves on the Cancer Care Delivery Research Committee for both the NRG and Alliance cooperative groups and the Young Investigators Committee for NRG.